Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

NCT00144664 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Juvenile Idiopathic Arthritis

Interventions

DRUG: MRA(Tocilizumab)

Sponsor

Chugai Pharmaceutical